<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101589534</journal-id><journal-id journal-id-type="pubmed-jr-id">40864</journal-id><journal-id journal-id-type="nlm-ta">JAMA Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Intern Med</journal-id><journal-title-group><journal-title>JAMA internal medicine</journal-title></journal-title-group><issn pub-type="ppub">2168-6106</issn><issn pub-type="epub">2168-6114</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24887552</article-id><article-id pub-id-type="pmc">4655589</article-id><article-id pub-id-type="doi">10.1001/jamainternmed.2014.2227</article-id><article-id pub-id-type="manuscript">HHSPA734415</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Health and Safety Issues for Travelers Attending the World Cup and Summer Olympic and Paralympic Games in Brazil, 2014 to 2016</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gaines</surname><given-names>Joanna</given-names></name><degrees>PhD, MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Sotir</surname><given-names>Mark J.</given-names></name><degrees>PhD, MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Cunningham</surname><given-names>Timothy J.</given-names></name><degrees>ScD</degrees></contrib><contrib contrib-type="author"><name><surname>Harvey</surname><given-names>Kira A.</given-names></name><degrees>MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Virginia Lee</surname><given-names>C.</given-names></name><degrees>MD, MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Stoney</surname><given-names>Rhett J.</given-names></name><degrees>MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Gershman</surname><given-names>Mark D.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Brunette</surname><given-names>Gary W.</given-names></name><degrees>MD, MS</degrees></contrib><contrib contrib-type="author"><name><surname>Kozarsky</surname><given-names>Phyllis E.</given-names></name><degrees>MD</degrees></contrib><aff id="A1">Geographic Medicine and Health Promotion Branch, Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia (Gaines, Sotir, Harvey, Lee, Stoney, Gershman, Brunette, Kozarsky); Epidemiology and Surveillance Branch, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia (Cunningham); Emory University School of Medicine, Atlanta, Georgia (Kozarsky)</aff></contrib-group><author-notes><corresp id="FN1">Joanna Gaines, PhD, MPH, Geographic Medicine and Health Promotion Branch, Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E-03, Atlanta, GA 30333 (<email>JGaines@cdc.gov</email>)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>11</month><year>2015</year></pub-date><volume>174</volume><issue>8</issue><fpage>1383</fpage><lpage>1390</lpage><!--elocation-id from pubmed: 10.1001/jamainternmed.2014.2227--><abstract><sec id="S1"><title>IMPORTANCE</title><p id="P1">Travelers from around the globe will attend the 2014 F&#x000e9;d&#x000e9;ration Internationale de Football Association (FIFA) World Cup and the 2016 Olympic and Paralympic Games in Brazil. Travelers to these mass gathering events may be exposed to a range of health risks, including a variety of infectious diseases. Most travelers who become ill will present to their primary care physicians, and thus it is important that clinicians are aware of the risks their patients encountered.</p></sec><sec id="S2"><title>OBJECTIVE</title><p id="P2">To highlight health and safety concerns for people traveling to these events in Brazil so that health care practitioners can better prepare travelers before they travel and more effectively diagnose and treat travelers after they return.</p></sec><sec id="S3"><title>EVIDENCE REVIEW</title><p id="P3">We reviewed both peer-reviewed and gray literature to identify health outcomes associated with travel to Brazil and mass gatherings. Thirteen specific infectious diseases are described in terms of signs, symptoms, and treatment. Relevant safety and security concerns are also discussed.</p></sec><sec id="S4"><title>FINDINGS</title><p id="P4">Travelers to Brazil for mass gathering events face unique health risks associated with their travel.</p></sec><sec id="S5"><title>CONCLUSIONS AND RELEVANCE</title><p id="P5">Travelers should consult a health care practitioner 4 to 6 weeks before travel to Brazil and seek up-to-date information regarding their specific itineraries. For the most up-to-date information, health care practitioners can visit the Centers for Disease Control and Prevention (CDC) Travelers&#x02019; Health website (<ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel">http://wwwnc.cdc.gov/travel</ext-link>) or review CDC&#x02019;s Yellow Book online (<ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014">http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014</ext-link>).</p></sec></abstract></article-meta></front><body><p id="P6">Brazil will host millions of travelers at 3 major mass gathering events: the 2014 F&#x000e9;d&#x000e9;ration Internationale de Football Association (FIFA) World Cup, and the 2016 Olympic Games and Paralympic Games.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> Mass gathering spose complex public health challenges, and with these events being held in the same country within a limited time span, these challenges may be exacerbated. Venues are located across Brazil. FIFA&#x02019;sWorld Cup will be held in 12 cities (<xref rid="F1" ref-type="fig">Figure 1A</xref>)<sup><xref rid="R1" ref-type="bibr">1</xref></sup> and the Olympic and Paralympic Games will be located near Rio de Janeiro (<xref rid="F1" ref-type="fig">Figure 1B</xref>).<sup><xref rid="R2" ref-type="bibr">2</xref></sup></p><p id="P7">Mass gatherings have been associated with adverse health events and can increase infectious disease transmission because of the influx of travelers, crowding at venues, poor hygiene from temporary food and sanitation facilities, challenging security situations, and unfamiliar public infrastructure.<sup><xref rid="R3" ref-type="bibr">3</xref>-<xref rid="R5" ref-type="bibr">5</xref></sup> During the 2008 World Youth Day in Sydney, Australia, an influenza outbreak was caused by at least 6 distinct influenza viruses.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Meningococcal disease outbreaks followed a 1997 football tournament in Belgium<sup><xref rid="R7" ref-type="bibr">7</xref></sup> and the 2000 Hajj in Saudi Arabia.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> During the 1996 Atlanta Olympic Games, more than 1000 people received health care for heat-related conditions.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p><p id="P8">Because the Centers for Disease Control and Prevention (CDC) recommends all travelers visit a medical practitioner 4 to 6 weeks prior to travel, we provide information for health care practitioners, including an overview of Brazil, relevant medical conditions and preventive measures, and general safety and security issues.</p><sec disp-level="2" id="S7"><title>Brazil&#x02014;The Host Country</title><p id="P9">Brazil is the largest country in South America, covering 8 514 877 km<sup>2.10</sup> Brazil has a population of more than 200 million; 87% lived in urban areas in 2010. Many host cities for events are overcrowded, including S&#x000e3;o Paulo (approximately 20 million population) and Rio de Janeiro (approximately 12 million). Portuguese is the official language.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>Transportation conditions vary throughout Brazil: only 13.5%of roads are paved.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> Urban subways are available in S&#x000e3;o Paulo, Rio de Janeiro, and Recife.<sup><xref rid="R11" ref-type="bibr">11</xref></sup></p></sec><sec id="S8"><title>Infectious Disease Risks for Travelers to Brazil and Disease-Specific Prevention Recommendations</title><sec id="S9"><title>Routine Vaccines</title><p id="P10">Diseases prevented by routine vaccination are prevalent in Brazil. Medical practitioners can ensure travelers are current on all routine vaccines (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec id="S10"><title>Hepatitis A and B</title><p id="P11">Hepatitis A, transmitted by food, water, or direct person-to-person contact,<sup><xref rid="R16" ref-type="bibr">16</xref></sup> is characterized by any combination of the following symptoms: fever, anorexia, jaundice, nausea, vomiting, and abdominal pain. Diagnosis typically involves a compatible clinical picture, elevations of hepatic enzyme levels, and detection of IgM antibodies to hepatitis A. Treatment is supportive. Domestic incidence of hepatitis A varies across Brazil and was approximately 7.5 to 11 cases per 100 000 persons during 2000 through 2005.<sup><xref rid="R17" ref-type="bibr">17</xref></sup>The CDC recommends all travelers receive hepatitis A vaccine. The first of the 2-dose series can be administered up to departure, providing most travelers adequate protection. For long-term protection, the second dose should be given after6months. For those suspected of having had illness previously, a serological test for IgG to hepatitis A may be performed prior to vaccination.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup>Hepatitis B virus is transmitted through blood or other body fluids.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Acute hepatitis B virus may cause a febrile illness including nausea, vomiting, rashes, joint pain, and jaundice; chronic infection can lead to liver disease, including cirrhosis and liver cancer.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Diagnosis involves recognition of the clinical syndrome along with laboratory evidence for hepatitis B.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> Treatment of acute illness is supportive. The prevalence of chronic carriers of hepatitis B virus in Brazil is 2% to 7%.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> The CDC recommends all travelers to Brazil be vaccinated for hepatitis B.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Travelers should have as many doses of the series as possible before travel. An accelerated regimen and a hepatitis A and B combined vaccine are available.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup></p></sec><sec id="S11"><title>Typhoid and Paratyphoid Fever</title><p id="P12">Typhoid, also a risk for travelers to Brazil, is transmitted via contaminated food or water. Symptoms range from fever to more severe disease that includes abdominal pain, headache, myalgia, nausea, and anorexia.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Serious complications include intestinal hemorrhage, perforation, or even death.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Paratyphoid fever is a similar but typically less severe form of typhoid fever. Because many patients present with fever and other nondiagnostic constitutional symptoms, diagnosis is often difficult. Blood, urine, or stool cultures may be positive, but bone marrow cultures, now very rarely done, are most sensitive. If either diagnosis is suspected, patients may be treated with broad-spectrum antibiotics,<sup><xref rid="R22" ref-type="bibr">22</xref></sup> including a quinolone (there may be some resistance to these), azithromycin, or a third-generation cephalosporin until a diagnosis is confirmed.</p><p id="P13">The CDC recommends typhoid fever vaccine for all travelers to Brazil.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Two vaccines are licensed: an inactivated injectable vaccine and a live, attenuated vaccine taken orally. Both provide 55% to 70% protection.<sup><xref rid="R23" ref-type="bibr">23</xref></sup>No vaccine is available for paratyphoid fever. Other preventive measures include food and beverage precautions (described in the &#x0201c;Gastrointestinal Illness and Travelers&#x02019; Diarrhea&#x0201d; section).<sup><xref rid="R22" ref-type="bibr">22</xref></sup></p></sec><sec id="S12"><title>Yellow Fever</title><p id="P14">Yellow fever virus is transmitted by the bite of an infected mosquito, primarily <italic>Aedes</italic> or<italic>Haemagogus</italic>species. Yellow fever virus infection is often a symptomatic; when disease occurs it can range from a nonspecific viral syndrome to severe disease with jaundice, multiorgan failure, hemorrhage, and death. Yellow fever should be suspected when an unimmunized traveler returns with fever from an endemic area. Clinicians suspecting yellow fever should contact their state or local health department or call the CDC Arboviral Disease Branch (<xref rid="T2" ref-type="table">Table 2</xref>). Treatment is exclusively supportive. Yellow fever vaccine is recommended for all travelers 9 months or older traveling to areas within Brazil with risk of yellow fever virus transmission (<xref rid="F1" ref-type="fig">Figure 1A</xref>).<sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup>The live, attenuated yellow fever vaccine is rarely associated with serious or fatal adverse events.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Contraindications include, but are not limited to, age younger than6months, allergy to any vaccine component, and altered immune status.<sup><xref rid="R25" ref-type="bibr">25</xref>-<xref rid="R27" ref-type="bibr">27</xref></sup> Precautions include age 6 to 8 months, age 60 years or older, a symptomatic human immunodeficiency virus infection with moderate immune suppression, pregnancy, and breastfeeding.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> Clinicians should review each traveler&#x02019;s medical history and itinerary to evaluate risk of yellow fever disease vs risk from vaccine. The online Yellow Fever Vaccination Center Registry lists US clinics authorized to administer vaccine (<ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel/yellow-fever-vaccination-clinics/search">http://wwwnc.cdc.gov/travel/yellow-fever-vaccination-clinics/search</ext-link>). Clinicians should educate travelers on preventive measures against mosquito bites, including using insect repellents, wearing long-sleeved permethrin-treated clothing, choosing rooms with air conditioning or intact screens, and sleeping under an insecticide-treated bed net.<sup><xref rid="R28" ref-type="bibr">28</xref></sup></p></sec><sec id="S13"><title>Meningococcal Disease</title><p id="P15">Caused by <italic>Neisseria meningitidis</italic>, meningococcal disease is endemic in Brazil. Meningococcal disease, characterized by headache, fever, stiff neck, nausea, and altered mental status, can result in severe disease and death.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> Outbreaks in Brazil have been primarily due to serotypes B and C.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> Travelers suspected of having meningitis should be treated aggressively with broad-spectrum antibiotic coverage, such as third-generation cephalosporin and vancomycin. Vaccines currently available in the United States are not protective against serogroup B.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> Because <italic>N meningitides</italic> is transmissible via close contact with respiratory secretions, travelers staying in crowded housing (eg, hostels) may benefit from a meningococcal conjugate vaccine.</p></sec><sec id="S14"><title>Rabies</title><p id="P16">Rabies is an acute, progressive, fatal encephalomyelitis that is endemic in Brazil.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> Illness generally occurs after a bite from a rabid mammal; nonbite transmissions are rare but can occur, such as via aerosol from bats in caves.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> The CDC recommends the preexposure vaccination of 3 doses (administered on days0, 7, and 21 or 28) for some travelers, including those who might be in direct contact with bats or stray animals.<sup><xref rid="R31" ref-type="bibr">31</xref></sup>Review of a traveler&#x02019;s itinerary may help identify potential exposures, such as a trip that involves handling animals in the Amazon rain forest.<sup><xref rid="R33" ref-type="bibr">33</xref></sup>The CDC does not recommend that travelers begin the 3-dose series if they are unable to complete it before departure. Because preexposure vaccine is not entirely protective<sup><xref rid="R31" ref-type="bibr">31</xref></sup> and the disease highly fatal, health care practitioners should educate travelers about animal avoidance and the importance of prompt health care for postexposure prophylaxis and immediate and thorough wound cleaning with soap and water should any bite occur.</p></sec><sec id="S15"><title>Malaria</title><p id="P17">Malaria is transmitted by mosquito bites (<italic>Anopheles</italic> species). Infection, characterized by fever, chills, headache, myalgia, and malaise, can result in severe illness and death.<sup><xref rid="R34" ref-type="bibr">34</xref></sup> Nearly all malaria cases in Brazil occur in the Amazon region, where the 2014 World Cup host cities Cuiaba and Manaus are located (<xref rid="F1" ref-type="fig">Figure 1A</xref>).<sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup></p><p id="P18">Medical practitioners should advise travelers about malaria chemoprophylaxis based on travel itineraries. Because of widespread chloroquine resistance in Brazil, atovaquone&#x02013;proguanil hydrochloride (Malarone; GlaxoSmithKline), doxycycline, or mefloquine hydrochloride (Lariam [Roche] and generic) are recommended for chemoprophylaxis.<sup><xref rid="R24" ref-type="bibr">24</xref></sup> Determination of which medication to use is based on age, underlying medical conditions, and cost.<sup><xref rid="R34" ref-type="bibr">34</xref></sup> Travelers should follow the mosquito bite prevention measures detailed in the &#x0201c;Yellow Fever&#x0201d; section. The Department of State (<ext-link ext-link-type="uri" xlink:href="http://www.usembassy.gov">http://www.usembassy.gov</ext-link>) and some travel health insurance companies can assist with identifying local medical services for travelers who develop a fever while traveling. Health care practitioners should inform travelers to urgently seek medical care if they develop fever following travel to a malaria-endemic area. A rapid malaria antigen detection test along with three blood smears at 8-hour intervals should be evaluated for parasites. Assistance in diagnosis and treatment can be obtained from an infectious diseases or tropical medicine clinician, as well as from the CDC malaria branch (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec><sec id="S16"><title>Dengue</title><p id="P19">Dengue is endemic to Brazil and is transmitted by the bite of a mosquito (primarily <italic>Aedesaegypti</italic>). <italic>Aedes</italic> mosquitoes feed during the day and typically live indoors in dark, cool places.<sup><xref rid="R36" ref-type="bibr">36</xref></sup> More than 4 million cases of dengue were reported in Brazil during 1986 through 2006.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Patients may have a mild, nonspecific febrile syndrome with headache and myalgia, although up to 5% may develop severe, life threatening disease with hemorrhagic signs and symptoms.<sup><xref rid="R36" ref-type="bibr">36</xref></sup> Treatment is supportive; early recognition of severe dengue is critical to reducing morbidity. Neither a vaccine nor chemoprophylaxis is available to prevent dengue. Healthcare practitioners should educate travelers on the mosquito bite prevention measures previously described.</p></sec><sec id="S17"><title>Gastrointestinal Illness and Travelers&#x02019; Diarrhea</title><p id="P20">Pathogenssuchas<italic>Escherichiacoli</italic>,<italic>Campylobacter</italic>species,<italic>Giardia</italic>species, and norovirus are common causes of travelers&#x02019; diarrhea.<sup><xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R39" ref-type="bibr">39</xref></sup> A review of ill travelers returning from Brazil between 1997 and 2013 found that gastrointestinal illness accounted for 34% of all diagnoses.<sup><xref rid="R40" ref-type="bibr">40</xref></sup>Healthcare practitioners should educate travelers on the importance of frequent handwashing with soap and water and use of alcohol-based hand sanitizers to decrease their risk of gastrointestinal illness.<sup><xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup> Other recommended approaches to reduce risk include food and water precautions and the use of nonantimicrobial drugs for prophylaxis.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> Freshly cooked food that is served hot is less likely to be contaminated than foods that have been sitting out. Travelers should avoid raw foods, such as salads, unpeeled fruits, or uncooked vegetables. Tap water may contain viruses, bacteria, or parasites and may be unsafe for drinking, preparing food, or for making ice. Travelers may choose to boil, filter, or otherwise treat water for consumption, although this may not remove chemical contaminants.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> Choosing unopened, factory-sealed beverages and avoiding ice in drinks may decrease the risk of travelers&#x02019; diarrhea.</p><p id="P21">Travelers&#x02019; diarrhea usually resolves within 48 hours.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> Ill travelers should maintain a high intake of nonalcoholic fluids to prevent dehydration and avoid dairy products. The effectiveness of a singledose or 3 days of antibiotic therapy with a fluoroquinolone or azithromycin, along with over-the-counter loperamide hydrochloride to ease symptoms, iswell established for self-treatment. Bismuth subsalicylate, the active ingredient in Pepto-Bismol (Procter &#x00026; Gamble), is a nonantimicrobial drug useful for mild travelers&#x02019; diarrhea if it has not been used for prophylaxis. Health care practitioners should review a traveler&#x02019;s medical history as those taking anticoagulants, probenecid, or methotrexate and travelers with aspirin allergy, renal insufficiency, and gout should avoid taking bismuth subsalicylate.<sup><xref rid="R39" ref-type="bibr">39</xref></sup></p><p id="P22">If travelers&#x02019; diarrhea does not resolve, is not responsive to self-treatment, or is accompanied by high fever or bloody diarrhea, travelers should immediately seek medical attention. Because travelers&#x02019; diarrhea leads to fluid and electrolyte loss, oral rehydration salts should be considered if diarrhea and/or vomiting occur. Both bismuth subsalicylate and rehydration salts are widely available at stores and pharmacies.<sup><xref rid="R39" ref-type="bibr">39</xref></sup></p></sec><sec id="S18"><title>Leishmaniasis</title><p id="P23">Leishmaniasis is caused by the protozoan parasite <italic>Leishmania</italic> species, spread primarily through the bite of infected sand flies.<sup><xref rid="R42" ref-type="bibr">42</xref></sup> It has rarely been seen in travelers returning from Brazil.<sup><xref rid="R40" ref-type="bibr">40</xref></sup> The most common form of leishmaniasis in travelers is a dermatologic infection called cutaneous leishmaniasis, which is characterized by skin lesions that may develop weeks or months after infection as small papules or nodular plaques, progressing to ulcers that may scale or crust (<xref rid="F2" ref-type="fig">Figure 2</xref>). No vaccines or drugs are available to prevent leishmaniasis; healthcare practitioners should educate travelers on vector prevention practices, such as those described in the yellow fever section. Diagnosis usually involves identification of the parasites in a skin biopsy. A number of treatment regimens are available depending on the species identified. See <xref rid="T2" ref-type="table">Table 2</xref> for medical practitioner resources.</p></sec><sec id="S19"><title>Schistosomiasis</title><p id="P24">Schistosomiasis is caused by <italic>Schistosoma</italic> species parasites. Infection occurs when the larval form penetrates the skin, typically when a person swims or bathes infresh water.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> Brazil is endemic for schistosomiasis, and outbreaks have been reported, including one in the 2014 World Cup site of Belo Horizonte.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> Patients with acute schistosomiasis (Katayama syndrome) may have fever, headache, myalgia, diarrhea, painful hepatomegaly or splenomegaly, and respiratory symptoms.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> Diagnosis is confirmed by microscopic identification of parasite eggs in stool or urine or by serological testing. Serological testing should be done at least 3 months following exposure. Referral to someone with expertise in treating schistosomiasis is recommended (<xref rid="T2" ref-type="table">Table 2</xref>).<sup><xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup></p></sec><sec id="S20"><title>Leptospirosis</title><p id="P25">Leptospirosis is a bacterial infection transmitted through breaks in the skin or through conjunctiva and mucous membranes via contact with urine or reproductive fluids from infected animals or by contact with water or soil contaminated by these fluids.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> Symptoms include an acute febrile illness with headache (potentially severe with retroorbital pain and photophobia), which can progress to severe disease (Weil disease). Diagnosis is typically based on clinical recognition of the often biphasicillness. Blood, urine, or spinal fluid cultures may yield results, along with serological testing. Nucleic acid amplification (polymerase chain reaction) may also be available.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> Treatment includes antibiotics such as penicillins and tetracyclines (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec><sec id="S21"><title>Skin Conditions</title><p id="P26">Dermatologic issues are common among travelers to Brazil.<sup><xref rid="R40" ref-type="bibr">40</xref></sup>Wearing appropriate clothing and using insect repellent can limit insect bites.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> The use of high&#x02013;UV protection factor (UV protection factor &#x0003e;30) sunscreen and clothing is recommended to prevent sunburn.<sup><xref rid="R47" ref-type="bibr">47</xref></sup></p><p id="P27">Bed bugs (<italic>Cimex lectularius</italic>) are common worldwide; infestations can occur in hotels.<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R48" ref-type="bibr">48</xref></sup> Travelers who see evidence of bed bugs, such as blood spotting on bed linens or the bugs themselves (reddish brown, 1-7mmlong) should request alternate lodging.<sup><xref rid="R28" ref-type="bibr">28</xref></sup></p><p id="P28">Cutaneous larva migrans, known as hookworm, is transmitted via contaminated soil or sand and has been documented in travelers to Brazil.<sup><xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R49" ref-type="bibr">49</xref>,<xref rid="R50" ref-type="bibr">50</xref></sup> Infected travelers may have a creeping eruption (<xref rid="F2" ref-type="fig">Figure 2</xref>). Most often, skin on the foot and buttocks is affected. Larva migrans can be treated by using albendazole or ivermectin.<sup><xref rid="R50" ref-type="bibr">50</xref>,<xref rid="R51" ref-type="bibr">51</xref></sup> Travelers can reduce their risk of infection by wearing shoes and using barriers (eg, towels) when sitting on the ground.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> Various treatment regimens exist, most notably oral albendazole or ivermectin.</p><p id="P29">Tungiasis is caused by the flea <italic>Tunga penetrans</italic>. These parasites become embedded in the epidermis, where they mature and produce eggs until their death up to 5 weeks later (<xref rid="F2" ref-type="fig">Figure 2</xref>). Because the fleas remain partially extruded from the skin, pathogens can enter through the break in the skin. The periungual regions of the toes are the preferred penetration site of <italic>T penetrans</italic>, but they can penetrate skin anywhere on the body.<sup><xref rid="R52" ref-type="bibr">52</xref></sup> Tungiasis is common in impoverished areas of Brazil.<sup><xref rid="R53" ref-type="bibr">53</xref></sup>Wearing closed-toe shoes may limit exposure; treatment requires extraction of the parasite.</p></sec><sec id="S22"><title>Sexually Transmitted Infections</title><p id="P30">A systematic review of studies of travel-associated sexual behavior calculated a pooled prevalence of 20.4% for casual sex, of which 49.4% is unprotected.<sup><xref rid="R54" ref-type="bibr">54</xref></sup> Health care practitioners should advise travelers to avoid unprotected sex with new partners while traveling. Condoms can decrease risk and should be purchased prior to departure to ensure they are of sufficient quality. Assessment of a traveler with a suspected sexually transmitted disease includes screening for others such as human immunodeficiency virus and hepatitis B.</p></sec></sec><sec id="S23"><title>Psychological Stress and Mental Health</title><p id="P31">Travel may lead to psychological stress, which can intensify symptoms in persons with preexisting mental health conditions such as depression or anxiety disorders.<sup><xref rid="R55" ref-type="bibr">55</xref>,<xref rid="R56" ref-type="bibr">56</xref></sup> Health care practitioners should consider psychiatric history, recent life stressors, and the use of any medication that may have adverse central nervous system effects. People with preexisting mental health conditions should not use mefloquine for malaria chemoprophylaxis because this may have adverse effects.<sup><xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R55" ref-type="bibr">55</xref></sup></p></sec><sec id="S24"><title>Safety and Security Issues</title><p id="P32">The crime rate is high inmost of urban Brazil, with murder and other crime rates more than 4 times higher than in the United States.<sup><xref rid="R57" ref-type="bibr">57</xref></sup> Travelers are often the targets of street crime, especially during evening hours. A review of general safety issues when traveling has been published elsewhere.<sup><xref rid="R58" ref-type="bibr">58</xref></sup> Before beginning international travel, US citizens should register their itineraries with the Smart Traveler Enrollment Program (STEP), a free service that allows the US Department of State to better assist travelers in the event of an emergency; travelers can enroll online at <ext-link ext-link-type="uri" xlink:href="https://step.state.gov/step/">https://step.state.gov/step/</ext-link>.</p></sec><sec id="S25"><title>Road Safety</title><p id="P33">In 2008, 39 211 deaths due to road traffic were documented in Brazil.<sup><xref rid="R59" ref-type="bibr">59</xref></sup> The Brazilian federal government maintains a Portuguese language website with information on road conditions and downloadable roadmaps.<sup><xref rid="R60" ref-type="bibr">60</xref>,<xref rid="R61" ref-type="bibr">61</xref></sup>Travelers who drive should familiarize themselves with local laws. Traffic signs may be written in Portuguese. Travelers should ensure all cars include basic safety equipment, such as seat belts, which should always be worn. Travelers can dial 190 to seek assistance from local police departments; this service is in Portuguese only.<sup><xref rid="R57" ref-type="bibr">57</xref></sup></p></sec><sec id="S26"><title>Pretravel and Posttravel Health Care and Travel Insurance</title><p id="P34">Travelers to Brazil should visit a medical practitioner for a pretravel consultation 4 to 6 weeks before departure. Consultations should include a review of the traveler&#x02019;s medical history and itinerary, administration of immunizations and chemoprophylaxis, and discussion of other preventive measures.<sup><xref rid="R62" ref-type="bibr">62</xref></sup> Health care practitioners who are not comfortable providing pretravel consultations or who do not have necessary vaccines in stock should refer patients to a travel medicine specialist<sup><xref rid="R63" ref-type="bibr">63</xref></sup>; a listing of travel clinics is available online at <ext-link ext-link-type="uri" xlink:href="http://www.istm.org.For">http://www.istm.org.For</ext-link> the most current health information, health care practitioners can visit the CDC Travelers&#x02019; Health website (<ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel">http://wwwnc.cdc.gov/travel</ext-link>) or review CDC&#x02019;s Yellow Book online (<ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014">http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014</ext-link>).</p><p id="P35">Before departure, travelers should contact their health insurance company to determine whether their policy includes coverage overseas and for emergency expenses such as aeromedical evacuation. Travelers are advised to consider supplemental travel health insurance with specific overseas coverage, including 24-hour access to assistance for health care and medical evacuation contingency plans.<sup><xref rid="R64" ref-type="bibr">64</xref>,<xref rid="R65" ref-type="bibr">65</xref></sup></p><p id="P36">Travelers who become sick or injured while traveling should seek immediate health care if they have fever, diarrhea with high fever, bloody diarrhea, or an animal bite or scratch or have been involved in an automobile accident or assaulted. Several illnesses associated with fever, including malaria, dengue, influenza, and typhoid fever, can become symptomatic in the first 2weeks on returning from travel.<sup><xref rid="R66" ref-type="bibr">66</xref>,<xref rid="R67" ref-type="bibr">67</xref></sup></p></sec><sec sec-type="conclusions" id="S27"><title>Conclusions</title><p id="P37">Travel to Brazil for mass gatherings has potential health risks. Travelers should consult their health care practitioner 4 to 6weeks before travel. Because health advice may need to be adapted quickly in response to environmental conditions, disease outbreaks, and political situations, the CDC recommends that travelers seek up-to-date health and safety information at <ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel">http://wwwnc.cdc.gov/travel</ext-link>. Lastly, travelers who develop fever during or after travel to Brazil should immediately seek health care. Health care practitioners should ask patients presenting with illness about any travel history.</p></sec></body><back><fn-group><fn id="FN2" fn-type="conflict"><p><bold>Conflict of Interest Disclosures:</bold> None reported.</p></fn><fn id="FN3" fn-type="other"><p><bold>Disclaimer:</bold> The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="web"><collab>F&#x000e9;d&#x000e9;ration Internationale de Football Association</collab><source>The official website of the FIFA World Cup</source><date-in-citation>September 6, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.fifa.com/worldcup">http://www.fifa.com/worldcup</ext-link></comment></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="web"><article-title>Rio 2016 Organizing Committee for the Games of the XXXI Olympiad</article-title><source>The official website of the 2016 Rio Olympic Games</source><date-in-citation>September 30, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.rio2016.org/en/the-games/olympic/event">http://www.rio2016.org/en/the-games/olympic/event</ext-link></comment></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abubakar</surname><given-names>I</given-names></name><name><surname>Gautret</surname><given-names>P</given-names></name><name><surname>Brunette</surname><given-names>GW</given-names></name><etal/></person-group><article-title>Global perspectives for prevention of infectious diseases associated with mass gatherings</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">22192131</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Stephens</surname><given-names>GM</given-names></name><name><surname>Steffen</surname><given-names>R</given-names></name><name><surname>Ahmed</surname><given-names>QA</given-names></name></person-group><article-title>Emergence of medicine for mass gatherings: lessons from the Hajj</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">22192130</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McCloskey</surname><given-names>B</given-names></name><name><surname>Endericks</surname><given-names>T</given-names></name></person-group><source>Learning From London 2012: A Practical Guide to Public Health and Mass Gatherings</source><publisher-loc>London, England</publisher-loc><publisher-name>Health Protection Agency London WHO Collaborating Centre</publisher-name><year>2013</year></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blyth</surname><given-names>CC</given-names></name><name><surname>Foo</surname><given-names>H</given-names></name><name><surname>van Hal</surname><given-names>SJ</given-names></name><etal/></person-group><collab>World Youth Day 2008 Influenza Study Group</collab><article-title>Influenza outbreaks during World Youth Day 2008 mass gathering</article-title><source>Emerg Infect Dis</source><year>2010</year><volume>16</volume><issue>5</issue><fpage>809</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">20409371</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reintjes</surname><given-names>R</given-names></name><name><surname>Kistemann</surname><given-names>T</given-names></name><name><surname>MacLehose</surname><given-names>L</given-names></name><etal/></person-group><article-title>Detection and response to a meningococcal disease outbreak following a youth football tournament with teams from four European countries</article-title><source>Int J Hyg Environ Health</source><year>2002</year><volume>205</volume><issue>4</issue><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12068748</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera</surname><given-names>J-F</given-names></name><name><surname>Perrocheau</surname><given-names>A</given-names></name><name><surname>Meffre</surname><given-names>C</given-names></name><name><surname>Hahn&#x000e9;</surname><given-names>S</given-names></name></person-group><collab>W135Working Group</collab><article-title>Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000</article-title><source>Emerg Infect Dis</source><year>2002</year><volume>8</volume><issue>8</issue><fpage>761</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">12141959</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetterhall</surname><given-names>SF</given-names></name><name><surname>Coulombier</surname><given-names>DM</given-names></name><name><surname>Herndon</surname><given-names>JM</given-names></name><name><surname>Zaza</surname><given-names>S</given-names></name><name><surname>Cantwell</surname><given-names>JD</given-names></name></person-group><collab>Centers for Disease Control and Prevention Olympics Surveillance Unit</collab><article-title>Medical care delivery at the 1996 Olympic Games</article-title><source>JAMA</source><year>1998</year><volume>279</volume><issue>18</issue><fpage>1463</fpage><lpage>1468</lpage><pub-id pub-id-type="pmid">9600481</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="web"><collab>US Central Intelligence Agency</collab><source>The world factbook: Brazil 2013</source><date-in-citation>September 21, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://www.cia.gov/library/publications/the-world-factbook/geos/br.html">https://www.cia.gov/library/publications/the-world-factbook/geos/br.html</ext-link></comment></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><collab>United States Federal Research Division</collab><source>Brazil: A Country Study</source><edition>5</edition><publisher-loc>Washington, DC</publisher-loc><publisher-name>Department of Defense</publisher-name><year>1998</year></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><collab>Centers for Disease Control and Prevention (CDC)</collab><article-title>Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices&#x02014;United States, 2013-2014</article-title><source>MMWR Recomm Rep</source><year>2013</year><volume>62</volume><issue>RR-07</issue><fpage>1</fpage><lpage>43</lpage></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>HQ</given-names></name><name><surname>Fiebelkorn</surname><given-names>AP</given-names></name><name><surname>Temte</surname><given-names>JL</given-names></name><name><surname>Wallace</surname><given-names>GS</given-names></name></person-group><collab>Centers for Disease Control and Prevention</collab><article-title>Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)</article-title><source>MMWR Recomm Rep</source><year>2013</year><volume>62</volume><issue>RR-04</issue><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">23760231</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><collab>Centers for Disease Control and Prevention (CDC)</collab><article-title>Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and a cellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2011</year><volume>60</volume><issue>1</issue><fpage>13</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">21228763</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>M</given-names></name><name><surname>G&#x000fc;ris</surname><given-names>D</given-names></name><name><surname>Chaves</surname><given-names>SS</given-names></name><name><surname>Schmid</surname><given-names>S</given-names></name><name><surname>Seward</surname><given-names>JF</given-names></name></person-group><collab>Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC)</collab><article-title>Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)</article-title><source>MMWR Recomm Rep</source><year>2007</year><volume>56</volume><issue>RR-4</issue><fpage>1</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">17585291</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharapov</surname><given-names>UM</given-names></name><name><surname>Teshale</surname><given-names>EH</given-names></name></person-group><article-title>Hepatitis A</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>183</fpage><lpage>186</lpage></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitral</surname><given-names>CL</given-names></name><name><surname>Souto</surname><given-names>FJ</given-names></name><name><surname>Gaspar</surname><given-names>AM</given-names></name></person-group><article-title>Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy</article-title><source>J Viral Hepat</source><year>2008</year><volume>15</volume><issue>(s2)(suppl 2)</issue><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">18837829</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>CB</given-names></name><name><surname>Woods</surname><given-names>L</given-names></name><name><surname>Coyne-Beasley</surname><given-names>T</given-names></name></person-group><collab>ACIP Adult Immunization Work Group; Centers for Disease Control and Prevention (CDC)</collab><article-title>Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older&#x02014;United States, 2013</article-title><source>MMWR Surveill Summ</source><year>2013</year><volume>62</volume><issue>suppl 1</issue><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">23364303</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Averhoof</surname><given-names>F</given-names></name></person-group><article-title>Hepatitis B</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>186</fpage><lpage>192</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab><source>Interpretation of hepatitis B serologic test results</source><date-in-citation>March 28, 2014</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hepatitis/hbv/pdfs/serologicchartv8.pdf">http://www.cdc.gov/hepatitis/hbv/pdfs/serologicchartv8.pdf</ext-link></comment></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>BA</given-names></name><name><surname>Patron</surname><given-names>DJ</given-names></name></person-group><article-title>Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler</article-title><source>J Occup Environ Med</source><year>2008</year><volume>50</volume><issue>8</issue><fpage>945</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">18695453</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>AE</given-names></name><name><surname>Mintz</surname><given-names>E</given-names></name></person-group><article-title>Typhoid and paratyphoid fever</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>319</fpage><lpage>322</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engels</surname><given-names>EA</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>Bennish</surname><given-names>ML</given-names></name></person-group><article-title>Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity</article-title><source>BMJ</source><year>1998</year><volume>316</volume><issue>7125</issue><fpage>110</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">9462316</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gershman</surname><given-names>MD</given-names></name><name><surname>Jentes</surname><given-names>ES</given-names></name><name><surname>Johnson</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Travel vaccines and malaria information, by country</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>347</fpage><lpage>404</lpage></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staples</surname><given-names>JE</given-names></name><name><surname>Gershman</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name></person-group><collab>Centers for Disease Control and Prevention (CDC)</collab><article-title>Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)</article-title><source>MMWR Recomm Rep</source><year>2010</year><volume>59</volume><issue>RR-7</issue><fpage>1</fpage><lpage>27</lpage></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gershman</surname><given-names>MD</given-names></name><name><surname>Jentes</surname><given-names>ES</given-names></name></person-group><article-title>Yellow fever</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>329</fpage><lpage>343</lpage></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab><source>Guide to vaccine contraindications and precautions</source><date-in-citation>September 17, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/vaccines/recs/vac-admin/downloads/contraindications-guide-508.pdf">http://www.cdc.gov/vaccines/recs/vac-admin/downloads/contraindications-guide-508.pdf</ext-link></comment></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nasci</surname><given-names>RS</given-names></name><name><surname>Zielinski-Gutierrez</surname><given-names>E</given-names></name><name><surname>Wirtz</surname><given-names>RA</given-names></name><name><surname>Brogdon</surname><given-names>WG</given-names></name></person-group><article-title>Protection against mosquitoes, ticks, and other insects and arthropods</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>94</fpage><lpage>98</lpage></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>A</given-names></name><name><surname>MacNeil</surname><given-names>JR</given-names></name></person-group><article-title>Meningococcal Disease</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>254</fpage><lpage>258</lpage></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halperin</surname><given-names>SA</given-names></name><name><surname>Bettinger</surname><given-names>JA</given-names></name><name><surname>Greenwood</surname><given-names>B</given-names></name><etal/></person-group><article-title>The changing and dynamic epidemiology of meningococcal disease</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>suppl 2</issue><fpage>B26</fpage><lpage>B36</lpage><pub-id pub-id-type="pmid">22178525</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rupprecht</surname><given-names>CE</given-names></name><name><surname>Shlim</surname><given-names>DR</given-names></name></person-group><article-title>Rabies</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>270</fpage><lpage>276</lpage></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>RV</given-names></name></person-group><article-title>Cryptogenic rabies, bats, and the question of aerosol transmission</article-title><source>Ann Emerg Med</source><year>2002</year><volume>39</volume><issue>5</issue><fpage>528</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">11973559</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Rosa</surname><given-names>ES</given-names></name><name><surname>Kotait</surname><given-names>I</given-names></name><name><surname>Barbosa</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Bat-transmitted human rabies outbreaks, Brazilian Amazon</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><issue>8</issue><fpage>1197</fpage><lpage>1202</lpage><pub-id pub-id-type="pmid">16965697</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Arguin</surname><given-names>PM</given-names></name><name><surname>Tan</surname><given-names>KR</given-names></name></person-group><article-title>Malaria</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>228</fpage><lpage>246</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira-Ferreira</surname><given-names>J</given-names></name><name><surname>Lacerda</surname><given-names>MV</given-names></name><name><surname>Brasil</surname><given-names>P</given-names></name><name><surname>Ladislau</surname><given-names>JL</given-names></name><name><surname>Tauil</surname><given-names>PL</given-names></name><name><surname>Daniel-Ribeiro</surname><given-names>CT</given-names></name></person-group><article-title>Malaria in Brazil: an overview</article-title><source>Malar J</source><year>2010</year><volume>9</volume><fpage>115</fpage><pub-id pub-id-type="pmid">20433744</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tomashek</surname><given-names>KM</given-names></name><name><surname>Margolis</surname><given-names>HS</given-names></name></person-group><article-title>Dengue</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>165</fpage><lpage>172</lpage></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>RMR</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>JM</given-names></name><name><surname>Schatzmayr</surname><given-names>HG</given-names></name></person-group><article-title>Dengue viruses in Brazil, 1986-2006</article-title><source>Rev Panam Salud Publica</source><year>2007</year><volume>22</volume><issue>5</issue><fpage>358</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">18198045</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>DuPont</surname><given-names>HL</given-names></name><name><surname>Ramsey</surname><given-names>DJ</given-names></name></person-group><article-title>Global etiology of travelers&#x02019; diarrhea: systematic review from 1973 to the present</article-title><source>Am J Trop Med Hyg</source><year>2009</year><volume>80</volume><issue>4</issue><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">19346386</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>BA</given-names></name></person-group><article-title>Travelers&#x02019; diarrhea</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>57</fpage><lpage>62</lpage></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Chen</surname><given-names>LH</given-names></name><name><surname>Han</surname><given-names>PV</given-names></name><etal/></person-group><collab>GeoSentinel Surveillance Network</collab><article-title>Illness in returned travelers from Brazil: the GeoSentinel experience and implications for the 2014 FIFA World Cup and the 2016 Summer Olympics</article-title><source>Clin Infect Dis</source><pub-id pub-id-type="doi">10.1093/cid/ciu122</pub-id><comment>published online ahead of print February 28, 2014</comment></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>JC</given-names></name><name><surname>Hlavsa</surname><given-names>MC</given-names></name><name><surname>Griffin</surname><given-names>PM</given-names></name></person-group><article-title>Food and water precautions</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>81</fpage><lpage>84</lpage></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Herwaldt</surname><given-names>BL</given-names></name><name><surname>Magill</surname><given-names>AJ</given-names></name></person-group><article-title>Leishmaniasis, cutaneous</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>222</fpage><lpage>224</lpage></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>S</given-names></name></person-group><article-title>Schistosomiasis</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>287</fpage><lpage>291</lpage></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enk</surname><given-names>MJ</given-names></name><name><surname>Amorim</surname><given-names>A</given-names></name><name><surname>Schall</surname><given-names>VT</given-names></name></person-group><article-title>Acute schistosomiasis outbreak in the metropolitan area of Belo Horizonte, Minas Gerais: alert about the risk of unnoticed transmission increased by growing rural tourism</article-title><source>Mem Inst Oswaldo Cruz</source><year>2003</year><volume>98</volume><issue>6</issue><fpage>745</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">14595449</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolls</surname><given-names>DJ</given-names></name><name><surname>Weld</surname><given-names>LH</given-names></name><name><surname>Schwartz</surname><given-names>E</given-names></name><etal/></person-group><collab>GeoSentinel Surveillance Network</collab><article-title>Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008</article-title><source>Am J Trop Med Hyg</source><year>2008</year><volume>79</volume><issue>5</issue><fpage>729</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">18981513</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stoddard</surname><given-names>RA</given-names></name><name><surname>Guerra</surname><given-names>MA</given-names></name></person-group><article-title>Leptospirosis</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>226</fpage><lpage>227</lpage></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ansdell</surname><given-names>VE</given-names></name><name><surname>Reisenauer</surname><given-names>AK</given-names></name></person-group><article-title>Sunburn</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>99</fpage><lpage>100</lpage></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>SW</given-names></name><name><surname>Svoboda</surname><given-names>TJ</given-names></name><name><surname>De Jong</surname><given-names>IJ</given-names></name><name><surname>Kabasele</surname><given-names>KJ</given-names></name><name><surname>Gogosis</surname><given-names>E</given-names></name></person-group><article-title>Bed bug infestations in an urban environment</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><issue>4</issue><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">15829190</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heukelbach</surname><given-names>J</given-names></name><name><surname>Gomide</surname><given-names>M</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>F</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Cutaneous larvamigrans and tungiasis in international travelers exiting Brazil: an airport survey</article-title><source>J Travel Med</source><year>2007</year><volume>14</volume><issue>6</issue><fpage>374</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">17995532</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>S</given-names></name></person-group><article-title>Cutaneous larvamigrans</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>163</fpage></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Enden</surname><given-names>E</given-names></name><name><surname>Stevens</surname><given-names>A</given-names></name><name><surname>Van Gompel</surname><given-names>A</given-names></name></person-group><article-title>Treatment of cutaneous larva migrans</article-title><source>N Engl JMed</source><year>1998</year><volume>339</volume><issue>17</issue><fpage>1246</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">9786758</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisele</surname><given-names>M</given-names></name><name><surname>Heukelbach</surname><given-names>J</given-names></name><name><surname>Van Marck</surname><given-names>E</given-names></name><etal/></person-group><article-title>Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil, I: natural history of tungiasis in man</article-title><source>Parasitol Res</source><year>2003</year><volume>90</volume><issue>2</issue><fpage>87</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">12756541</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muehlen</surname><given-names>M</given-names></name><name><surname>Heukelbach</surname><given-names>J</given-names></name><name><surname>Wilcke</surname><given-names>T</given-names></name><name><surname>Winter</surname><given-names>B</given-names></name><name><surname>Mehlhorn</surname><given-names>H</given-names></name><name><surname>Feldmeier</surname><given-names>H</given-names></name></person-group><article-title>Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil, II: prevalence, parasite load and topographic distribution of lesions in the population of a traditional fishing village</article-title><source>Parasitol Res</source><year>2003</year><volume>90</volume><issue>6</issue><fpage>449</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">12768415</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivancos</surname><given-names>R</given-names></name><name><surname>Abubakar</surname><given-names>I</given-names></name><name><surname>Hunter</surname><given-names>PR</given-names></name></person-group><article-title>Foreign travel, casual sex, and sexually transmitted infections: systematic review and meta-analysis</article-title><source>Int J Infect Dis</source><year>2010</year><volume>14</volume><issue>10</issue><fpage>e842</fpage><lpage>e851</lpage><pub-id pub-id-type="pmid">20580587</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Valk</surname><given-names>TH</given-names></name></person-group><article-title>Mental health and travel</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>136</fpage><lpage>137</lpage></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>J</given-names></name><name><surname>Reilly</surname><given-names>T</given-names></name><name><surname>Edwards</surname><given-names>B</given-names></name></person-group><article-title>The stress of travel</article-title><source>J Sports Sci</source><year>2004</year><volume>22</volume><issue>10</issue><fpage>946</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">15768727</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="web"><collab>US Department of State</collab><source>Brazil: country-specific information</source><date-in-citation>October 12, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://travel.state.gov/content/passports/english/country/brazil.html">http://travel.state.gov/content/passports/english/country/brazil.html</ext-link></comment></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leggat</surname><given-names>PA</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name></person-group><article-title>Personal safety advice for travelers abroad</article-title><source>J Travel Med</source><year>2001</year><volume>8</volume><issue>1</issue><fpage>46</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">11182609</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandran</surname><given-names>A</given-names></name><name><surname>Sousa</surname><given-names>TR</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Bishai</surname><given-names>D</given-names></name><name><surname>Pechansky</surname><given-names>F</given-names></name></person-group><collab>Vida No Transito Evaluation Team</collab><article-title>Road traffic deaths in Brazil: rising trends in pedestrian and motorcycle occupant deaths</article-title><source>Traffic Inj Prev</source><year>2012</year><volume>13</volume><issue>suppl 1</issue><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/15389588.2011.633289</pub-id><pub-id pub-id-type="pmid">22414123</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="web"><source>Departamento de Policia Rodovi&#x000e1;ria</source><date-in-citation>April 24, 2014</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://www.prf.gov.br/PortalInternet/index.faces">https://www.prf.gov.br/PortalInternet/index.faces</ext-link></comment></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="web"><source>Minist&#x000e9;rio dos Transportes</source><date-in-citation>September 17, 2013</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.transportes.gov.br/">http://www.transportes.gov.br/</ext-link></comment></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LH</given-names></name></person-group><article-title>The pre-travel consultation</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>26</fpage><lpage>32</lpage></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>DR</given-names></name><name><surname>Ericsson</surname><given-names>CD</given-names></name><name><surname>Pearson</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2006</year><volume>43</volume><issue>12</issue><fpage>1499</fpage><lpage>1539</lpage><pub-id pub-id-type="pmid">17109284</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sommers</surname><given-names>TE</given-names></name></person-group><article-title>Travel insurance, travel health insurance and medical evacuation insurance</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>145</fpage><lpage>147</lpage></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leggat</surname><given-names>PA</given-names></name><name><surname>Carne</surname><given-names>J</given-names></name><name><surname>Kedjarune</surname><given-names>U</given-names></name></person-group><article-title>Travel insurance and health</article-title><source>J Travel Med</source><year>1999</year><volume>6</volume><issue>4</issue><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">10575173</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fairley</surname><given-names>JK</given-names></name></person-group><article-title>General approach to the returned traveler</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>470</fpage><lpage>473</lpage></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>ME</given-names></name></person-group><article-title>Fever in returned travelers</article-title><person-group person-group-type="editor"><name><surname>Brunette</surname><given-names>GW</given-names></name></person-group><source>CDC Health Information for International Travel 2014</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name><year>2014</year><fpage>474</fpage><lpage>479</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Venue Maps</title><p>A, F&#x000e9;d&#x000e9;ration Internationale de Football Association (FIFA) World Cup host cities with areas with malaria transmission and where yellow fever vaccine is recommended, Brazil, 2014. B, Venues for 2016 Olympic and Paralympic Games.</p><p><sup>a</sup>CDC Health Information for International Travel, 2014.</p></caption><graphic xlink:href="nihms734415f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Dermatologic Conditions Found in Brazil</title><p>Crater ulcers of various stages due to cutaneous leishmaniasis on the arm (A) (source: Centers for Disease Control and Prevention/Mae Melvin, MD); cutaneous larvamigrans (B) (source: Jay Keystone, University of Toronto); and tungiasis (C) (source: Mohammed Asmal and RocioM. Hurtado [this image was first published on Partners&#x02019; Infectious Disease Images website, whose content is copyrighted by Partners Healthcare System Inc and is used with permission. All rights reserved]).</p></caption><graphic xlink:href="nihms734415f2"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Routine Vaccine Recommendations for Travelers to Brazil, Advisory Council for Immunization Practices, 2013</p></caption><table frame="box" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Vaccine</th><th align="left" valign="bottom" rowspan="1" colspan="1">Acceptable Presumptive Evidence of Immunity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Recommendations for International Travelers</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Influenza<sup><xref rid="R12" ref-type="bibr">12</xref></sup></td><td align="left" rowspan="1" colspan="1">Because of seasonal variation in circulating influenza strain, annual immunizations are needed.</td><td align="left" rowspan="1" colspan="1">All travelers should receive seasonal influenza vaccine unless contraindicated.</td></tr><tr><td align="left" colspan="3" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="2" colspan="1">MMR<sup><xref rid="R13" ref-type="bibr">13</xref></sup></td><td align="left" rowspan="1" colspan="1">Adults born before 1957. Laboratory evidence of immunity OR laboratory confirmation of disease.</td><td align="left" rowspan="1" colspan="1">Children aged 6-11 mo should receive 1 dose of MMR vaccine.</td></tr><tr><td align="left" rowspan="1" colspan="1">Documentation of age-appropriate vaccination with a live measles virus-containing vaccine.</td><td align="left" rowspan="1" colspan="1">Children aged &#x02265;12 mo and adults should receive 2 doses of MMR vaccine separated by at least 28 d if not previously immunized.</td></tr><tr><td align="left" colspan="3" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="3" colspan="1">Tetanus, diphtheria, pertussis<sup><xref rid="R14" ref-type="bibr">14</xref></sup></td><td align="left" rowspan="3" colspan="1">Documentation of age-appropriate vaccination for tetanus, diphtheria, pertussis.</td><td align="left" rowspan="1" colspan="1">Children aged 11-18 y should receive 1 dose of tetanus toxoid, reduced Tdap vaccine.</td></tr><tr><td align="left" rowspan="1" colspan="1">All adults who have not previously received Tdap vaccine should receive 1 dose.</td></tr><tr><td align="left" rowspan="1" colspan="1">Adults aged &#x02265;19 y who have received 1-time dose of Tdap vaccine should receive booster with Td vaccine every 10 y afterwards.</td></tr><tr><td align="left" colspan="3" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="3" colspan="1">Varicella<sup><xref rid="R15" ref-type="bibr">15</xref></sup></td><td align="left" rowspan="1" colspan="1">History of varicella or herpes zoster based on diagnosis by a health care practitioner.</td><td align="left" rowspan="3" colspan="1">2 doses of vaccine &#x02265;4 wk apart for persons aged &#x02265;13 y.</td></tr><tr><td align="left" rowspan="1" colspan="1">Laboratory evidence of immunity OR laboratory confirmation of disease.</td></tr><tr><td align="left" rowspan="1" colspan="1">Documentation of vaccination.</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Abbreviations: MMR, measles, mumps, rubella; OR, operating room; Td, tetanus and diphtheria; Tdap, combined tetanus, diphtheria, and pertussis.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Diagnostic and Treatment Resources for Health Care Practitioners</p></caption><table frame="box" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">Resource</th><th align="left" rowspan="1" colspan="1">Contact Information</th><th align="left" rowspan="1" colspan="1">Assistance Available</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">American Society of Tropical Medicine and Hygiene</td><td align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.astmh.org/Home1.htm">http://www.astmh.org/Home1.htm</ext-link></td><td align="left" rowspan="1" colspan="1">Identify a nearby physician with clinical consultative service in tropical medicine, medical parasitology, travelers&#x02019; health</td></tr><tr><td align="left" rowspan="1" colspan="1">CDC&#x02019;s Arboviral Diseases Branch</td><td align="left" rowspan="1" colspan="1">Telephone: 970-221-6400</td><td align="left" rowspan="1" colspan="1">Yellow fever diagnostic testing; assessment of antibody response to yellow fever vaccination</td></tr><tr><td align="left" rowspan="1" colspan="1">CDC&#x02019;s Dengue Branch</td><td align="left" rowspan="1" colspan="1">Telephone: 800-232-4636 or 888-232-6348 <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/Dengue/">http://www.cdc.gov/Dengue/</ext-link></td><td align="left" rowspan="1" colspan="1">Clinical and laboratory guidance for dengue; resources for clinicians and laboratorians</td></tr><tr><td align="left" rowspan="1" colspan="1">International Society of Travel Medicine</td><td align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.istm.org">http://www.istm.org</ext-link></td><td align="left" rowspan="1" colspan="1">TravelMed listserv allows discussion of clinical cases, pretravel and posttravel medical issues; identify a nearby physician with expertise in travelers&#x02019; health, and some with tropical medicine experience</td></tr><tr><td align="left" rowspan="1" colspan="1">CDC&#x02019;s Malaria Branch</td><td align="left" rowspan="1" colspan="1">EST working hours, Monday-Friday: CDC Malaria Hotline at 770-488-7788 or 855-856-4713; After hours: Emergency Operations Center: 770-488-7100</td><td align="left" rowspan="1" colspan="1">Malaria diagnostics; treatment of malaria.</td></tr><tr><td align="left" rowspan="1" colspan="1">CDC&#x02019;s Parasitic Disease Inquiries</td><td align="left" rowspan="1" colspan="1">Telephone: 404-718-7475 <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/parasites">http://www.cdc.gov/parasites</ext-link></td><td align="left" rowspan="1" colspan="1">Diagnostics for leishmaniasis, schistosomiasis; treatment for leishmaniasis, schistosomiasis</td></tr><tr><td align="left" rowspan="1" colspan="1">CDC&#x02019;s Travelers&#x02019; Health Branch</td><td align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://wwwnc.cdc.gov/travel">http://wwwnc.cdc.gov/travel</ext-link></td><td align="left" rowspan="1" colspan="1">Access CDC Health Information for International Travel 2014 online</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Abbreviation: CDC, Centers for Disease Control and Prevention.</p></fn></table-wrap-foot></table-wrap></floats-group></article>